NEW YORK, NY
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)PROSTATE ACTION INC, founded in 2000, is a small nonprofit in the Medical Research sector that reported $226K in total revenue in fiscal year 2025. Revenue surged 415% from the prior year, signaling strong growth momentum. The organization ran a surplus of $52K, a strong 23% operating margin.
THE PROSTATE ACTION, INC. AWARDS TRAVEL GRANTS TO RESEARCHERS FOR TRAVEL TO ATTEND SYMPOSIUMS AND MEETINGS ON PROSTATE CANCER AND RESEARCH. IN ADDITION RESEARCH AWARDS ARE GRANTED AND DISBURSED TO RESEARCHERS. PROSTATE ACTION, INC. HOLDS INFORMATIONAL SEMINARS IN NEW YORK CITY AS UPDATES ON THE VARIOUS PROSTATE RESEARCH BEING CONDUCTED. ALSO THE LOCATION OF THE SEMINARS WAS CHOSEN TO ENSURE ACCESSIBILITY TO A WIDE RANGE OF CONSTITUENTS.
GRANTS TO MT SINAI SCHOOL OF MEDICINE FOR RESEARCH. IN ADDITION RESEARCH AWARDS ARE GRANTED AND DISBURSED TO RESEARCHERS. PROSTATE ACTION, INC. HOLDS INFORMATIONAL SEMINARS IN NEW YORK CITY AS...
GRANTS TO MT SINAI SCHOOL OF MEDICINE FOR RESEARCH. IN ADDITION RESEARCH AWARDS ARE GRANTED AND DISBURSED TO RESEARCHERS. PROSTATE ACTION, INC. HOLDS INFORMATIONAL SEMINARS IN NEW YORK CITY AS UPDATES ON THE VARIOUS PROSTATE RESEARCH BEING CONDUCTED. ALSO THE LOCATION OF THE SEMINARS WAS CHOSEN TO ENSURE ACCESSIBILITY TO A WIDE RANGE OF CONSTITUENTS. PROOF OF PRINCIPLE RESEARCH REGARDING ANTIBODIES AND CANCER CELLS. RESEACH TO DEVELOP NEW ANTIBODIES THAT NEUTRALIZE PROSTATIC ACID PHOSPHATASE, A PROTEIN SECRETED BY PROSTATE CANCER CELLS THAT SPREAD TO BONE.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2025 | 2024 | Change | |
|---|---|---|---|
| Revenue | $226,354 | $43,932 | +4.2% |
| Expenses | $174,092 | $96,258 | +0.8% |
| Net Income | $52,262 | $-52,326 | -2.0% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| ALEXANDER KIRSCHENBAUM MD | PRESIDENT | 0.10 |
Officer
Director
|
$11,250 | $0 | $11,250 |
| ALICE LEVINE MD | VICE PRESIDENT | 0.10 |
Officer
Director
|
$0 | $0 | $0 |
| MS DIANE G KRANZ | BOARD MEMBER | 0.10 |
Director
|
$0 | $0 | $0 |
| MR JOSEPH EDELMAN | CHAIRMAN | 0.10 |
Officer
Director
|
$0 | $0 | $0 |
| SAMARA LEVINE | BOARD MEMBER | 0.10 |
Director
|
$0 | $0 | $0 |
| ALAN GELBAND | BOARD MEMBER | 0.10 |
Director
|
$0 | $0 | $0 |
| EDGAR CORDERO | SECRETARY | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| SUZANNE LEVINE MD | BOARD MEMBER | 0.10 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $226,354 | $174,092 | $559,353 | $52,262 |
| 2025 | $226,354 | $174,092 | $559,353 | $52,262 |
| 2024 | No data | No data | No data | No data |
| 2023 | $150,921 | $39,130 | $559,416 | $111,791 |
| 2022 | $152,280 | $92,517 | $450,873 | $59,763 |
| 2021 | $129,529 | $155,193 | $391,110 | $-25,664 |
| 2020 | $226,202 | $49,646 | $416,774 | $176,556 |
| 2019 | $273,040 | $57,228 | $240,218 | $215,812 |
Compare PROSTATE ACTION INC with other nonprofits in New York and across the country.